中国医学前沿杂志（电子版）2023，Vol.15Issue(11)：1-8,8.DOI:10.12037/YXQY.2023.11-01
生物制剂在银屑病治疗中的临床实践
Clinical practice of biological agents therapy for psoriasis
蔡祯 1陶娟1
作者信息
- 1. 华中科技大学同济医学院附属协和医院 皮肤科,湖北 武汉 430022
- 折叠
摘要
Abstract
Psoriasis is a chronic inflammatory skin disease that greatly affects the lives of patients due to its incurable and recurrent nature.In recent years,with the availability and clinical practice of biologic agents,many patients who failed to respond to traditional treatments have more options.Currently the biologics that have been marketed and put into clinical use include TNF-α(tumor necrosis factor)inhibitors,interleukin(IL)-12/IL-23 inhibitors,IL-17A inhibitors and IL-36 inhibitors,which have brought considerable improvement to many patients with psoriasis due to their outstanding efficacy and stable safety profile.This article provides a review of the eleven mainstream biologic agents and summarizes their actual efficacy,adverse effects and precautions.关键词
银屑病/生物制剂/治疗/安全性Key words
Psoriasis/Biological agents/Therapy/Safety引用本文复制引用
蔡祯,陶娟..生物制剂在银屑病治疗中的临床实践[J].中国医学前沿杂志（电子版）,2023,15(11):1-8,8.
